Only reason i think it was more like 25% is becaus

Quote:

---

Only reason i think it was more like 25% is because I can't see the FDA letting the trial run if mortality reduction achieved was 50%.

---

Going by FDA guidance the DSMC would be the only ones to know what the mortality reduction was unless the trial was halted. If the trial was just under the predetermined mortality endpoint the report to Cytodyn might read something like "predetermined p value was not achieved but trial should continue.". Cytodyn would have no idea how close we are.